Mesoblast lifts Ryoncil sales 60% as new US$125m facility strengthens balance sheetMesoblast (ASX:MSB; Nasdaq:MESO) has ...

Aristocrat Leisure's decision to extend its on-market share buyback program by $750 million has been met with positive ...

US defence stocks have commenced 2026 with robust performance, continuing the strong momentum from the previous year.

Champion Iron has announced that rail services on the Quebec North Shore and Labrador Railway have resumed following a ...

Mesoblast has reported a strong December quarter, with gross revenues of $US35.1 million ($52.4 million) from sales of its ...

Atlas Arteria has announced that its Autoroutes Paris-Rhin-Rhône (APRR) venture has successfully priced €500 million of bonds ...

TD Securities has adjusted its forecast, now anticipating a rate hike at the Reserve Bank of Australia's (RBA) first policy ...

The US trade deficit experienced a significant contraction in October, according to data released by the Commerce ...

Mesoblast Limited (ASX:MSB; Nasdaq:MESO), a global leader in allogeneic cellular medicines for inflammatory diseases, has reported a 60% increase in gross revenue from Ryoncil sales for the quarter ...

Silver prices have declined for a second consecutive day as investors adjust their positions in anticipation of annual ...

Max Riaz, Investment Manager of Sovereign Advisors, and Billy Leung, Senior Investment Strategist at Global X, explore ...

Kalamazoo Resources Limited (ASX: KZR), an ASX-listed exploration company focused on gold and base metals projects in ...